How itraconazole affects a new drug in healthy adults
This early-stage study tests how a common antifungal medication (itraconazole) changes how your body processes a new experimental drug called HS-10506. Researchers enroll healthy volunteers to understand safe dosing before testing in patients with real medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old
- Have a healthy weight (BMI 19–26 kg/m²)
- Be willing to use non-hormonal contraception for 3 months after your last study dose
- Not have serious medical conditions affecting your heart, lungs, stomach, liver, or mental health
- Stop all regular medications, supplements, and herbal products 2 weeks before starting (except some topical treatments)
- Avoid alcohol, smoking, and grapefruit for the duration of the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if taking itraconazole, an antifungal medicine, changes how the body processes the investigational drug HS-10504. It helps researchers understand safe dosing and potential side effects.
This trial tests a new drug called Lu AH69593 in healthy volunteers to see how safe it is and how the body handles it. Participation involves staying at the clinic for a while and requires a health check.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This study tests a new medicine called HS-10504 in healthy adults to see how the body processes it. It helps find the right dose and check for side effects.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
This trial studies how the drug clifutinib is processed by the body when taken with other medicines (itraconazole, fluconazole, or efavirenz). Healthy volunteers will receive a single dose of clifutinib plus one of these other drugs to see how they affect each other.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.